Cerezyme

Indicated For

Gaucher disease type 1, Gaucher disease type 3

About This Medication

# Sanofi Cares North America Patient Assistance Program Guide: Getting Cerezyme at Low Cost ## What is Cerezyme? Cerezyme (imiglucerase) is a prescription medication used to treat Gaucher disease types 1 and 3. This rare genetic disorder affects how your body breaks down certain fats. Cerezyme can be expensive, but Sanofi offers assistance to help eligible patients access this critical medication. ## Who Can Apply? You may qualify for the Sanofi Cares North America Patient Assistance Program if you: - Have been prescribed Cerezyme for Gaucher disease type 1 or type 3 - Have no insurance coverage for this medication, OR your insurance has denied coverage - Meet the program's income requirements (income limits vary by household size and location) If your income exceeds the program's limits, you may still qualify for a savings card that reduces your out-of-pocket costs. ## Income Requirements Income eligibility varies based on your household size and state of residence. The program uses federal poverty guidelines as a reference point. Most programs accept patients with household incomes up to 400% of the federal poverty level, though this can vary. When you apply, you'll provide your household income information, and the program will determine your eligibility. If you don't qualify based on income, ask about the Cerezyme savings card, which offers discounts on your medication regardless of income level. ## Insurance Requirements You're eligible to apply if: - **You have no health insurance**, OR - **Your insurance denied coverage** for Cerezyme If you have insurance that covers Cerezyme, you should use your insurance first. The patient assistance program is designed for those without coverage or whose insurance won't pay. ## How to Apply: 4 Simple Steps **Step 1: Gather Your Documents** Before applying, have these ready: - Your CareConnect PAP application form (your doctor's office can provide this) - Proof of income (recent tax return, pay stubs, or benefit statements) - Insurance information (if applicable) or proof of denial - Identification and Social Security number - Contact information for your prescribing physician **Step 2: Contact the Program** Call the Sanofi Cares North America Patient Assistance Program at **(800) 745-4447**. A representative will answer your questions and guide you through the application process. You can also apply online at https://pro.campus.sanofi/us/products/cerezyme/access-billing-reimbursement. **Step 3: Submit Your Application** Return your completed CareConnect PAP application and supporting documents. You can submit them by: - Phone: (800) 745-4447 - Mail: Address provided by the program - Online portal: https://pro.campus.sanofi/us/products/cerezyme/access-billing-reimbursement **Step 4: Receive Approval and Your Medication** Once approved, the program will coordinate with your pharmacy to deliver your Cerezyme. You won't need to reapply each year—your approval continues as long as your circumstances remain the same. ## Timeline Most applications are reviewed within 7-10 business days. Once approved, your medication can typically be shipped or picked up within 1-2 weeks. Don't delay—apply as soon as your doctor prescribes Cerezyme. ## Savings Card Option If you don't qualify for free medication through the patient assistance program, Sanofi offers a savings card. This card can reduce your out-of-pocket costs significantly, regardless of income. Ask your doctor's office or pharmacist about enrolling. ## What Happens Next? No reauthorization is required—once you're approved, your assistance continues. If your circumstances change (income, insurance status), notify the program. Refills are automatic, so you won't run out of medication. ## Need More Help? If your application is denied or you have questions, call (800) 745-4447. A patient advocate can explain next steps and discuss alternative options, including the savings card. Getting Cerezyme shouldn't be a financial burden. The Sanofi Cares North America Patient Assistance Program exists to ensure you can afford your medication. Take the first step today.

Program information last verified: March 25, 2026